Avecho Biotechnology Limited (ASX:AVE) Receives $1.66M R&D Tax Incentive
Avecho Biotechnology Limited (ASX:AVE) receives $1.66M under the R&D Tax Incentive to support its Phase III insomnia trial and commercialization efforts.
Category: ASX-AVE
Avecho Biotechnology Limited
Avecho Biotechnology Limited (ASX:AVE) Receives US$3M Licensing Fee from Sandoz
Avecho Biotechnology Limited (ASX:AVE) receives a US$3M upfront licensing fee from Sandoz AG for its CBD treatment for insomnia in Australia.